Image

Clinical Evaluation of Frequency Allocation for Bimodal CI Users

Clinical Evaluation of Frequency Allocation for Bimodal CI Users

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This study will examine experienced, bimodal cochlear implant (CI) patients who receive an alternative frequency allocation table (FAT) to determine how it improves sound quality, device satisfaction, and speech perception abilities with respect to the standard default FAT. The goal of this study is to investigate how improving place-pitch mismatch in bimodal CI users affects 1) sound quality, 2) satisfaction, and 3) speech perception.

Eligibility

Inclusion Criteria:

  1. Age 18 or older
  2. Regular usage of a cochlear implant device with at least 18 active electrodes, and compliance with programming/appointments
  3. Received a cochlear implant at least 6 months ago and use a hearing aid in the contralateral ear
  4. Pure tone average (.5, 1, and 2kHz) between 30 and 70 dB (decibel) hearing level in the contralateral (hearing aid) ear
  5. Standard FAT use for all programs prior to study participation
  6. No known anatomical abnormalities in either ear
  7. English speaking
  8. No known cognitive impairments
  9. At least 25% of subjects should use the Cochlear EA32 electrode

Exclusion Criteria:

  1. Under age 18
  2. Non-English speaking. Participants that are Non-English speaking are excluded from this study due to the use of speech testing materials that are validated in the English language. Additionally, study team members are not equipped to appropriately score speech testing materials validated in other languages.
  3. Cognitively impaired
  4. Non-consistent device usage
  5. Greater than 70 dB hearing level pure tone average in the contralateral ear
  6. Normal hearing or mild hearing loss in the contralateral ear
  7. Non-standard FAT programs
  8. Use of any frequency transposition programming in hearing aid.

Study details
    Hearing Impairment

NCT06663917

NYU Langone Health

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.